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Objective: There were no studies on the macrophage colony-stimulating factor (M-CSF), receptor activator of
NF-kappaB ligand (RANKL) and osteoprotegerin (OPG) in the pathogenesis of Kashin-Beck disease (KBD). The objective of
the present study was to investigate the serum M-CSF, RANKL and OPG in rats fed with KBD-affected diet.
Methods: Ninety Wistar rats were divided into five groups. The rats received standard commercial feed with or
without T-2 toxin additive, low protein feed with or without or T-2 toxin additive and the KBD-affected feed. The
serum bioactivity of M-CSF, RANKL and OPG was tested by enzyme-linked immunosorbent assay.
Results: The serum levels of M-CSF in E group rats were higher than those in the other groups in the five groups
(P < 0.01). The serum levels of RANKL and OPG in E group rats were highest in the five groups and have significant
difference compared to the other groups (P < 0.05).
Conclusions: The molecule of M-CSF, RANKL and OPG may be involved in the regulation of epiphyseal plate injury
and repair in KBD, and its participation in the pathogenesis of KBD should be studied in the future.
Keywords: Kashin-Beck disease, Macrophage colony-stimulating factor, Osteoprotegerin ligand receptor activator
of NF-kappaB ligand, OsteoprotegerinIntroduction
The important function of bone can be easily recognized
in day-to-day life, where millions of people suffer from
bone disease such as osteoporosis, which is, in part,
caused by an imbalance between bone formation and
bone resorption [1,2]. The better understanding of the
regulation of bone formation will provide new insights
into the molecular mechanisms of Kashin-Beck disease
(KBD), which usually afflicts children between the ages
of 5 and 13 years with epiphyseal plates showing focal or
irregular premature closure, wherein in the normal bone
formation, endochondral ossification ends up about
20 years after birth in humans [3-5]. Its initial pathologic
changes are multiple degenerative and necrotic lesions
within the growth plate cartilage. The secondary patho-
logic findings, visible on radiographs, are repairing and
remodeling around the necrotic foci of the cartilage of* Correspondence: ydlywl@126.com
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unless otherwise stated.the metaphysis, bone end and epiphysis [6-9]. With the
development of modern molecular biology technology,
there has been a focus on serum biomarkers as tools in
evaluating cartilage destruction [10]. However, there is
little understanding of the expression of these biological
molecules and the relationship with possible pathogenic
factors of KBD.
Based on epidemiological investigations, three main
hypotheses for the etiology of KBD are considered to be
selenium deficiency in food, hypoalimenation in food
and severe contamination of food by fungal mycotoxins
[11-15]. The high altitude of the A'ba Autonomous
Region of Sichuan province, just as Tibet, and the ex-
tremely severe weather conditions affect the availability
of natural resources and the use of land. Due to high
moisture content, the grains were particularly suscep-
tible to mould and infected by fungi [16-18]. Cereal
grain contamination by Fusarium spp. and Alternaria
sp. in endemic areas of China, and cereal samples in
high incidence areas of KBD were reported to be more
heavily contaminated with trichotecenes (T-2 toxins)
when compared to those in low incidence areas [19,20].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ribosomal subunit causing inhibition of protein, DNA
and RNA synthesis. Although T-2 toxin can inhibit the
proliferation of cartilage cells and reduce synthesis of
proteoglycan and collagen in epiphyseal plate through
metaphyseal rich and open capillary network, the fact is
that the blood system was the first target of T-2 toxin in-
volvement and bone marrow may be the main network
place other than the epiphyseal plate. However, there
has been little knowledge about the blood system and
bone marrow biological process that have been regulated
by T-2 toxin and the relationship with possible patho-
genic factors of KBD.
It is generally believed that bone marrow contains pro-
genitor cells both of osteoblasts and osteoclasts [21,22].
On the basis of bone marrow biological process regu-
lated by T-2 toxin, the microenvironment for progenitor
cells in bone marrow may play an important role in the
pathological changes of KBD [23]. At the molecular
level, several factors are known to cooperate in regulat-
ing the sequential steps of endochondral bone formation
in bone marrow, including the macrophage colony-
stimulating factor (M-CSF), receptor activator of NF-
kappaB ligand (RANKL) and osteoprotegerin (OPG)
[24-26]. RANKL is a transmembrane ligand expressed in
osteoblasts and bone marrow stromal cells and produced
by T cells. Following binding to RANK, a receptor vital
for osteoclast differentiation, activation and survival,
RANKL induces osteoclastogenesis in a pathway which
synergizes with signals derived from M-CSF. OPG, also
produced by osteoblasts and marrow stromal cells, lacks
a transmembrane domain and acts as a decoy receptor
for RANKL, thus regulating bone metabolism [27]. In
view of the bone formation and KBD which usually af-
flicts children between the ages of 5 and 13 years with
epiphyseal plates with focal or irregular premature clos-
ure, M-CSF/RANKL/OPG roles may be involved in the
regulation of epiphyseal plate injury and repair in KBD.
However, no paper has been published in this respect. In
this study, the serum concentrations of M-CSF, RANKL
and OPG were tested in order to evaluate their partici-
pation in the pathogenesis of KBD.
Materials and methods
Ninety weanling Wister rats (half were males and fe-
males, 4 weeks of age and with weight of 60 to 70 g)
were obtained from the Center of Laboratory Animals of
West China hospital, Sichuan University, Chengdu, Si-
chuan, People's Republic of China. The rats' rooms were
maintained at a temperature of 22°C with relative hu-
midity of 40%–70% and 12-h light/dark cycle. Prior to
initiation of dosing, all rats were quarantined for 1 week
and evaluated for weight gain and any gross sign of dis-
ease or injury. After quarantine, the rats were randomlydivided by a computerized blocking procedure into five
groups (every group has 18 rats). Group A was fed with a
normal diet as control, group B was fed with a normal diet
and T-2 toxin, group C was fed with a low nutrition diet
and T-2 toxin, group D was fed with a low nutrition
diet and group E was fed with a KBD-affected diet. All rats
were supplied with tap water that is freely accessible at all
times. Use of animals in this study was in accordance with
NIH publication 85-23 ‘Guide for Care and Use of
Laboratory Animals’ (NRC, 1996). The experiment was
approved by the Animal Ethics Committee, West
China school of Medicine, Sichuan University.
KBD-affected diet was made on the basis of the KBD-
affected family dietary pattern by the wheat and corn
samples, which were collected in October 2008 from
KBD-affected family which was located in Jinchuan
county of the A'ba region, Sichuan, People's Republic of
China. Normal diet was based from the commercial rats'
diet. The details of the dietary pattern and nutritional
constitution of diet can be seen in our previous report
[28,29]. Every rat has been feed sufficiently to avoid con-
flict caused by hunger (20 to 30 g diet for each rat every-
day). T-2 toxin was purchased from Trilogy Analytical
Laboratory (Washington, MO, USA) at a purity of 99%;
crystalline T-2 toxin was dissolved in absolute ethanol
and diluted with 0.9% normal saline. The T-2 toxin was
continuously administered intragastrically over 5 days in
1 week at levels of 0.04 mg/kg/day.
At 4, 8, and 12 weeks, six rats from each group were
randomly sacrificed after collecting blood samples. After
collection, blood samples were centrifuged and the
serum obtained was stored at −80°C up to measurement.
Serological investigations were carried out at the end of
the study in all serum samples taken at the different
time points. Assay were carried out to determine serum
levels of M-CSF, RANKL and OPG by a sandwich
enzyme-linked immunosorbent assay (ELISA), utilizing
two monoclonal antibodies directed against separate
antigenic determinants on the rat M-CSF, RANKL and
OPG. The kits for the assay were provided by Adlitteram
Diagnostic Laboratories Inc. (San Diego, CA, USA).
Statistical analyses
Statistical analyses were performed using SPSS Version
16.0 software. The data were expressed as the mean ±
SD and were analyzed using analysis of variance
(ANOVA). In the case of heterogeneity of variance,
transformations were used to stabilize the variance. Results
were considered statistically significant if the p value was
less than 0.05 for continuous variables.
Results
ELISA analyses were used to determine the serum le-
vels of M-CSF, RANKL and OPG in experiment rats
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the control group and low nutrition group rats in the
experience course at three time points (P > 0.05). The
serum levels of M-CSF in E group rats were highest in
the five groups at 4 and 8 weeks (411.85 ± 123.73 pg/ml
versus 589.62 ± 147.85 pg/ml, respectively) and have
significant difference compared to the other groups
(P < 0.01). However, there were no differences in every
group at 12 weeks (P > 0.05). C group rats just as the E
group have the highest serum levels of M-CSF at
8 weeks and have significant difference compared to
those at 4 weeks (376.30 ± 128.19 pg/ml versus 151.27 ±
81.22 pg/ml, P < 0.01).
The serum levels of RANKL in E group rats were
highest at 4 weeks (0.228 ± 0.085 ng/ml), which have
significant difference compared to the other groups at
4 weeks and compared to 8 or 12 week levels in E group
(P < 0.01). At 8 and 12 weeks, C group rats have the
highest serum levels of RANKL in five groups (0.178 ±
0.022 ng/ml versus 0.153 ± 0.027 ng/ml), which have sig-
nificant difference compared to A, B and D (P < 0.05)
and no significant difference compared to E (P > 0.05).
The serum levels of OPG were 2.688 ± 0.615 ng/ml in
E group at 4 weeks, which was highest in the five groups
and have significant difference compared to the other
groups (P < 0.05). However, there were no significant dif-
ferences among other groups at 4 weeks (P > 0.05). The
serum levels of OPG were highest in the A group at 8
and 12 week time points (P > 0.05). At 8 and 12 weeks,
the serum levels of OPG were 1.665 ± 0.597 ng/ml and
1.672 ± 0.476 ng/ml in A group rats, and there were no
significant difference with the other groups (P > 0.05).
Discussion
Although the pathology of Kashin-Beck disease may be
explained by the effect of mycotoxins, and different spe-
cies of fungi produce a wide range of mycotoxins, low
nutrition diet may be involved in the aetiology of KBD
[10,28-30].The A'ba region of Sichuan Province is anTable 1 Serum levels of M-CSF, RANKL and OPG
Item Time (weeks) A B
MCSF (pg/ml) 4 234.08 ± 82.08 116.61 ± 92
8 231.36 ± 85.53* 138.82 ± 95
12 232.56 ± 88.13 228.27 ± 76
RANKL (ng/ml) 4 0.034 ± 0.025# 0.079 ± 0.03
8 0.041 ± 0.017 0.084 ± 0.04
12 0.058 ± 0.013 0.072 ± 0.03
OPG (ng/ml) 4 1.415 ± 0.312※ 1.492 ± 0.39
8 1.665 ± 0.597 1.542 ± 0.36
12 1.672 ± 0.476 1.403 ± 0.62
There were difference in the groups of * compared to **, # compared to ## and ※
Mean ± SD.endemic area of KBD. It is located on the Tibetan plat-
eau, which has a high altitude and high humidity and a
low temperature region. The rat fed with KBD-affected
diet shows focal necrosis and irregular premature clos-
ure at epiphysis plate by microscopy examination. The
pathology of tibia growth cartilage and adjoining meta-
physeal bone showed T-2 toxin combined with low nu-
trition diet which retarded the growth of rats similar to
the changes of epiphysis plate with deep necrosis in
KBD, and the necrotic lesions in epiphysis cartilage were
multiple and localized in the deep zone of epiphyseal
plate. The basic pathological change of KBD is the epi-
physeal plate showing focal or irregular premature clos-
ure, which means that the normal bone formation of
endochondral ossification was destroyed. However, the
precise mechanism of chondrocyte necrosis and epiphys-
eal plate destruction in KBD remains unknown [31,32].
KBD-affected diets and low nutrition diet, which was
made on the basis of the KBD-affected family dietary
pattern which lacks some of the nutritional elements,
will lead to cell division, proliferation and self-repair
capacity decline [28,33]. Based on epidemiological inves-
tigations, mycotoxins are significantly associated with
the risk of KBD [10]. Cereal samples in high incidence
areas of KBD were found to be more seriously contami-
nated with trichothecenes when compared to those in
low incidence areas [20]. Through the metaphyseal rich,
open capillary network, T-2 toxin can inhibit the prolif-
eration of cartilage cells and reduce synthesis of proteo-
glycan and collagen. Although T-2 toxin can induce the
chondrocyte necrosis in animals, which bind to the
eukaryotic 60 S ribosomal subunit causing inhibition of
protein, DNA and RNA synthesis, it has no target cell
specificity. Thus, the mycotoxin, which was seen as im-
portant environmental factors in the pathogenesis of
Kashin-Beck disease, may have more complex network
in the body, especially in the blood and bone marrow
system [10]. The serum levels of M-CSF in KBD-affected
diet group rats and low nutrition diet combined with T-2C D E
.67 151.27 ± 81.22 246.76 ± 97.41 411.85 ± 123.73
.76* 376.30 ± 128.19* 259.64 ± 88.97* 589.62 ± 147.85**
.63 250.77 ± 95.40 248.09 ± 93.52 258.87 ± 89.86
8# 0.138 ± 0.059# 0.068 ± 0.017# 0.228 ± 0.085##
1 0.178 ± 0.022 0.052 ± 0.028 0.160 ± 0.059
8 0.153 ± 0.027 0.053 ± 0.011 0.105 ± 0.042
1※ 1.734 ± 0.778※ 1.324 ± 0.773※ 2.688 ± 0.615※※
3 1.376 ± 0.369 1.486 ± 0.598 1.359 ± 0.517
4 1.241 ± 0.134 1.461 ± 0.708 1.288 ± 0.612
compared to ※※, P < 0.01.
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groups, which means that the T-2 toxin not only induce the
chondrocyte necrosis but also affect the metabolic process
of M-CSF [34].
From the basic pathological change of epiphyseal plate
showing focal or irregular premature closure in KBD,
the destroyed bone formation of endochondral ossifica-
tion that is investigated may be a key for a KBD study
[30]. Recent studies have revealed an essential role of M-
CSF and RANKL in the development of osteoclasts, and
detailed molecular cascades that induce osteoclast differen-
tiation, activation and apoptosis have been clarified [25].
Molecular mechanisms of RANK/RANKL/OPG are keys in
osteoclast differentiation and activation in physiological and
pathological conditions. When RANKL and M-CSF bind
their receptors RANK and c-fms, respectively, osteoclast
precursor cells differentiate into osteoclasts [27,35,36].
KBD-affected diets and low nutrition diet, which was
made on the basis of the KBD-affected family dietary pat-
tern that lacks some of nutritional elements, will lead to
cell division, proliferation and self-repair capacity decline.
The serum levels of RANKL were highest in the KBD-
affected diet group rats.
The suppressed immunity and chronic hypoxia-induced
mitochondrial damage and apoptosis may play an import-
ant role in the pathogenesis of KBD [37-39]. OPG interferes
with the interactions between RANK and RANKL and in-
hibits osteoclast formation and function. It has been shown
that the RANKL/OPG ratio may determine the delicate
balance between bone resorption and synthesis [27]. Under
normal conditions, RANKL is mainly produced by osteo-
blasts and bone marrow stromal cells. However, in many
pathological conditions such as rheumatoid arthritis (RA)
and neoplastic osteolysis, RANKL is also produced by T
and B lymphocytes, macrophages/monocytes, fibroblasts,
synoviocytes and megakaryocytes. T-2 toxin and its accu-
mulating effect may cause a decrease in the normal rate of
osteoprogenitor cell differentiation to osteoblasts and oste-
ocytes [40]. The serum levels of OPG were highest in the
KBD-affected group rats. Based on these previous studies
[3-9], the aetiology of KBD not only causes epiphyseal plate
chondrocyte necrosis but also decreases epiphyseal plate
bone formation both by decreasing the rate of bone forma-
tion and increasing the bone resorption. Thus, the myco-
toxin, which are seen as exogenous free-radical carriers,
are important environmental factors in the pathogenesis of
Kashin-Beck disease [41,42], and selenium, vitamin C and
vitamin E, which inhibit free-radical formation, are consid-
ered to be protective [12,33].Conclusion
The molecule of M-CSF, RANKL and OPG may be in-
volved in the regulation of epiphyseal plate injury andrepair in KBD, and its participation in the pathogenesis of
KBD should be studied in the future.
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